logo
logo
Sign in
robert henric 2021-06-24
img

A combination of bottom-up and top-down approaches were used to calculate Viral Inactivation Market sizes and growth rates of the global market and its sub-segments.

Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players.

Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth ratesExpected Revenue Surge:The Global Viral Inactivation Market poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.The Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Market Segmentation in Detailed:By Method;Divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

collect
0
robert henric 2021-04-07
img

Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.According MarketsandMarkets™ Research – The report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.The Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Market Segmentation in Depth:By method, divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market in 2015.The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Of these the vaccines and therapeutics application hold the highest share.By end user, Segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Geographical View in-detailed:Segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).

collect
0
robert henric 2021-05-12
img

The report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global viral inactivation market along with the estimates and forecasts of the revenue and market share analysis.Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Viral Inactivation Market Segmentation in Detailed:By method, the market is divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market.By application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Of these the vaccines and therapeutics application hold the highest share.By end user, segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

collect
0
robert henric 2020-08-12
img

Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.According to the new market research report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast” published by MarketsandMarkets™.The Global Viral Inactivation Market poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.Major Market Growth Drivers:Rapid Growth in Pharmaceutical and Biotechnology IndustriesIncreasing Number of New Drug LaunchesStrong R Investments in the Life Sciences IndustryIncreasing Government Support for Pharmaceutical and Biotechnology IndustriesHigh Incidence and Large Economic Burden of Chronic DiseasesBrowse 72 market data tables with 70 figures spread through 154 pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Viral Inactivation MarketMarket Segmentation in Depth:By method, the market is divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market.By end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China). 

collect
0
robert henric 2021-07-05
img

The Research Report on “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast” published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.The Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Don’t miss out on business opportunities in “Viral Inactivation Market”.

Speak to Our Analyst and gain crucial industry insights that will help your business growth:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121427017Viral Inactivation Market Segmentation in Detailed:Based on end user, categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Based on geography the market is segmented into North America, Europe, Asia and Rest of the World (RoW).Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market in the forecasted period (2016-2021).

collect
0
robert henric 2020-05-07
img

The Global Viral Inactivation Market is expected to reach $ 320.5 million, will grow at a CAGR of 12.3%Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Browse and in-depth TOC on “Viral Inactivation Market”85 — Tables41 — Figures130 — PagesMajor Drivers For Viral Inactivation Market:· Rapid Growth in Pharmaceutical and Biotechnology Industries· Increasing Number of New Drug Launches· Strong R Investments in the Life Sciences Industry· Increasing Government Support for Pharmaceutical and Biotechnology Industries· High Incidence and Large Economic Burden of Chronic DiseasesMarket Segmentation in Depth:The global market is segmented based on method, product, application, end user, and geography.The method segments included in the report are solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Based on geography the market is segmented into North America, Europe, Asia and Rest of the World (RoW).Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017The major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).Geographic Analysis for Viral Inactivation MarketFurther breakdown of the viral inactivation market into specific countries/regions in Europe, and Rest of The WorldThe geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).

collect
0
robert henric 2020-03-13
img

Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses.

These biological products are used for the treatment and diagnostic purposes in humans.

As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise.

Also,  many of pharmaceutical and biotechnology firms are gearing to cater to the growing demands of medicines.

This aids to the growth of market.According to the new market research report "Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast", published by MarketsandMarkets™.The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017The Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach $573.0 Million.Global Market Segmentation in-detailed: By method, the market is divided into solvent detergent method, pasteurization, and other methods.

Of these, the solvent detergent method segment accounted for the largest share of the global market.The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

collect
0
robert henric 2021-06-24
img

A combination of bottom-up and top-down approaches were used to calculate Viral Inactivation Market sizes and growth rates of the global market and its sub-segments.

Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players.

Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth ratesExpected Revenue Surge:The Global Viral Inactivation Market poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.The Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Market Segmentation in Detailed:By Method;Divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

robert henric 2021-05-12
img

The report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global viral inactivation market along with the estimates and forecasts of the revenue and market share analysis.Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Viral Inactivation Market Segmentation in Detailed:By method, the market is divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market.By application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Of these the vaccines and therapeutics application hold the highest share.By end user, segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

robert henric 2021-07-05
img

The Research Report on “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast” published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.The Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Don’t miss out on business opportunities in “Viral Inactivation Market”.

Speak to Our Analyst and gain crucial industry insights that will help your business growth:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121427017Viral Inactivation Market Segmentation in Detailed:Based on end user, categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Based on geography the market is segmented into North America, Europe, Asia and Rest of the World (RoW).Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market in the forecasted period (2016-2021).

robert henric 2020-03-13
img

Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses.

These biological products are used for the treatment and diagnostic purposes in humans.

As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise.

Also,  many of pharmaceutical and biotechnology firms are gearing to cater to the growing demands of medicines.

This aids to the growth of market.According to the new market research report "Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast", published by MarketsandMarkets™.The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017The Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach $573.0 Million.Global Market Segmentation in-detailed: By method, the market is divided into solvent detergent method, pasteurization, and other methods.

Of these, the solvent detergent method segment accounted for the largest share of the global market.The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

robert henric 2021-04-07
img

Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.According MarketsandMarkets™ Research – The report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.The Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Market Segmentation in Depth:By method, divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market in 2015.The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Of these the vaccines and therapeutics application hold the highest share.By end user, Segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Geographical View in-detailed:Segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).

robert henric 2020-08-12
img

Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.According to the new market research report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast” published by MarketsandMarkets™.The Global Viral Inactivation Market poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.Major Market Growth Drivers:Rapid Growth in Pharmaceutical and Biotechnology IndustriesIncreasing Number of New Drug LaunchesStrong R Investments in the Life Sciences IndustryIncreasing Government Support for Pharmaceutical and Biotechnology IndustriesHigh Incidence and Large Economic Burden of Chronic DiseasesBrowse 72 market data tables with 70 figures spread through 154 pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017Viral Inactivation MarketMarket Segmentation in Depth:By method, the market is divided into solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market.By end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China). 

robert henric 2020-05-07
img

The Global Viral Inactivation Market is expected to reach $ 320.5 million, will grow at a CAGR of 12.3%Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.

Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017Browse and in-depth TOC on “Viral Inactivation Market”85 — Tables41 — Figures130 — PagesMajor Drivers For Viral Inactivation Market:· Rapid Growth in Pharmaceutical and Biotechnology Industries· Increasing Number of New Drug Launches· Strong R Investments in the Life Sciences Industry· Increasing Government Support for Pharmaceutical and Biotechnology Industries· High Incidence and Large Economic Burden of Chronic DiseasesMarket Segmentation in Depth:The global market is segmented based on method, product, application, end user, and geography.The method segments included in the report are solvent detergent method, pasteurization, and other methods.

Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Based on geography the market is segmented into North America, Europe, Asia and Rest of the World (RoW).Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017The major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).Geographic Analysis for Viral Inactivation MarketFurther breakdown of the viral inactivation market into specific countries/regions in Europe, and Rest of The WorldThe geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).